Neoplasms: all 9,610 studies
Page 86 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- Tissue Sample Collection From Patients With Fanconi AnemiaCompletedNCT00899522
- Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for CancerStatus unknownNCT00898794
- Capsule Endoscopy to Screen for Small Bowel Neoplasia in Lynch SyndromeCompletedNCT00898768Early Phase 1
- Collecting and Storing Tissue From Young Patients With CancerCompletedNCT00898755
- Gene Expression Profiles to Categorize Wilms TumorsCompletedNCT00897637
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
- Study of Erlotinib in Combination With BortezomibCompletedNCT00895687Phase 1
- Erlotinib in Combination With CetuximabCompletedNCT00895362Phase 1
- Study of Erlotinib in Combination With DasatinibCompletedNCT00895128Phase 1
- Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid MalignanciesCompletedNCT00894894Phase 1
- Pharmacologic Optimization of VoriconazoleCompletedNCT00893555Phase 3
- Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?CompletedNCT00892502Not applicable
- Methoxyamine and Temozolomide in Treating Patients With Advanced Solid TumorsCompletedNCT00892385Phase 1
- Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid TumorsCompletedNCT00891605Phase 1
- Amrubicin + Cyclophosphamide in Advanced Solid Organ MalignanciesCompletedNCT00890955Phase 1
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.CompletedNCT00890500Phase 1
- Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialCompletedNCT00890435
- Her2 and TGFBeta Cytotoxic T Cells in Treatment of Her2 Positive MalignancyCompletedNCT00889954Phase 1
- Safety/Biomarker Study of CNTO 95 and Avastin in Solid TumorsCompletedNCT00888043Phase 1
- Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid TumorsCompletedNCT00887757Phase 1
- Intrabone Infusion of Cord Blood in Adults With Hematological MalignanciesCompletedNCT00886522Phase 2
- Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid TumorsCompletedNCT00884845Phase 1
- Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid TumorsCompletedNCT00884676Phase 1
- Exercise During Chemotherapy for Patients With Hematological MalignanciesStatus unknownNCT00884364Phase 3
- Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver InvolvementCompletedNCT00882180Phase 1
- Repeat Dose Safety Study for Compound to Treat Hematologic CancerCompletedNCT00881946Phase 1/2
- Study of AS1411 in Advanced Solid TumoursCompletedNCT00881244Phase 1
- Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to TreatmentCompletedNCT00880282Phase 1
- FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced MalignanciesCompletedNCT00880074Phase 1
- A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid TumorsCompletedNCT00879905Phase 1
- A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid TumorsCompletedNCT00879554Phase 1
- Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid TumorsCompletedNCT00878904Phase 1
- Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid TumorsCompletedNCT00878423Phase 1
- Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid TumourCompletedNCT00878111Phase 1
- Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid TumorsCompletedNCT00877474Phase 1
- Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary CancerCompletedNCT00876408
- Epoetin Beta in Patients Undergoing Chemotherapy for Solid TumorsTerminatedNCT00875004Not applicable
- Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid TumorsCompletedNCT00874042Phase 1
- A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid MalignanciesCompletedNCT00871559Phase 1
- A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid TumorsCompletedNCT00869388Phase 1
- Radiofrequency Ablation (RFA) Of Tumors Acquired In ChildhoodSuspendedNCT00868647Phase 2
- Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory MalignancyCompletedNCT00863850Phase 1
- Study of DMXAA (Now Known as ASA404) in Solid TumorsCompletedNCT00863733Phase 1
- 4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung MetastasisCompletedNCT00862680
- Evaluation of Questionnaires of Tumor Patients With and Without Additive Homeopathic TherapyCompletedNCT00861432Phase 2
- In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor CryoablationCompletedNCT00861107Phase 1/2
- Pharmacodynamic Study of Axitinib in Patients With Advanced Solid MalignanciesCompletedNCT00859118Phase 1
- A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid TumorsCompletedNCT00858377Phase 1
- Test Semiquantitative Prostate Specific Antigen (PSA)CompletedNCT00853710Not applicable
- Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella ProtocolStatus unknownNCT00851032
- Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain TumorsCompletedNCT00850278Not applicable
- Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.CompletedNCT00849550Phase 1
- The Effect of Case Management in Complex Cancer PathwaysCompletedNCT00845247Not applicable
- Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2CompletedNCT00844064Phase 1
- A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid TumorsCompletedNCT00841191Phase 1/2
- A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory MalignanciesCompletedNCT00840190Phase 1
- Dose Escalation Study of EC D-3263 HCl in Advanced Solid TumorsCompletedNCT00839631Phase 1
- Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and MelanomaActive, not recruitingNCT00835133
- Safety Study of PEGPH20 Given to Patients With Advanced Solid TumorsCompletedNCT00834704Phase 1
- A Study of ARRY-334543 and Docetaxel in Patients With Advanced CancerCompletedNCT00833326Phase 1
- Adolescent and Young Adult Cancer Survivors: Identity DevelopmentActive, not recruitingNCT00832325
- Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological MalignanciesCompletedNCT00831896Phase 1
- The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast CancerCompletedNCT00830973
- Does Transcranial Magnetic Stimulation of the Cingulate Cortex Modulate the Perception of Dyspnoea?TerminatedNCT00830921
- A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid TumorsSuspendedNCT00827203Phase 1
- Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid TumorsCompletedNCT00827177Phase 1
- Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic MalignanciesCompletedNCT00825487Phase 1
- The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot StudyCompletedNCT00824278
- Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic MalignanciesCompletedNCT00824135Phase 1
- Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerCompletedNCT00823524Phase 1/2
- Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell MalignanciesCompletedNCT00823355Phase 1
- A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic MalignanciesWithdrawnNCT00820768Phase 1
- Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid MalignanciesCompletedNCT00820508Phase 1
- Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRITerminatedNCT00820456
- AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid TumoursTerminatedNCT00819221Phase 1
- A Phase 1 Study of AMG 208 in Subjects With Advanced Solid TumorsCompletedNCT00813384Phase 1
- Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00813072Phase 2
- Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous PolyposisCompletedNCT00808743Phase 2/3
- Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerCompletedNCT00806767Phase 2
- 99mTc-MIBI SPECT/CT in Breast MalignancyTerminatedNCT00804544Not applicable
- Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00804336Phase 1
- Lapatinib and Ixabepilone in Treating Patients With Advanced Solid TumorsTerminatedNCT00804310Phase 1
- Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard TherapyCompletedNCT00801177Phase 1
- Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to TreatmentTerminatedNCT00800150Phase 1
- Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced CancersCompletedNCT00798252Phase 1
- Photon/Proton Radiation Therapy for Carcinoma of the Skin of the Head and NeckTerminatedNCT00797043
- A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid TumorsCompletedNCT00794781Phase 1
- Study of IMC-1121B in Patients With Tumors That Have Not Responded to TherapyCompletedNCT00793975Phase 1
- Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid TumorsCompletedNCT00793897Phase 1
- Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening ColonoscopyStatus unknownNCT00792649
- Safety Study of ABT-263 in Combination With Rituximab in Lymphoid CancersCompletedNCT00788684Phase 1
- S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid TumorsWithdrawnNCT00788580Phase 1
- Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain TumorsStatus unknownNCT00787982Phase 1/2
- A Study Of PF-04554878 In Patients With Advanced Non-Hematologic MalignanciesCompletedNCT00787033Phase 1
- A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid TumorsCompletedNCT00786669Phase 1
- Community Cancer Centers Pilot Patient SurveyCompletedNCT00786656
- A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is AvailableCompletedNCT00785941Phase 1
- RDEA119 and Sorafenib Combination Dose Escalation StudyCompletedNCT00785226Phase 1/2
- A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid TumorsCompletedNCT00783328Phase 1